Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: A randomised clinical trial

Arab Journal of Gastroenterology

Volumn 12, Issue 3, 2011, Pages 150-153

  Seyyedmajidi, Mohammadreza ^a   Falaknazi, Kianoosh ^a   Mirsattari, Dariush ^a   Zojaji, Homayoun ^a   Roshani, Mohammad ^a   Lahmi, Farhad ^a   Orimi, Peyman Gooran ^a   Hadizadeh, Maryam ^a   Zali, Mohammadreza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Creatinine clearance; Helicobacter pylori; Treatment protocols

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; FURAZOLIDONE; OMEPRAZOLE;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DUODENITIS; DYSPEPSIA; ERADICATION THERAPY; ESOPHAGITIS; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HEMODIALYSIS; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; CIPROFLOXACIN; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTRITIS; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; UREMIA;

EID: 80455173922     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2011.07.004     Document Type: Article

References (26)

1. Al-Mueilo S.H. Gastroduodenal lesions and Helicobacter pylori infection in hemodialysis patients. Saudi Med J 2004, 25(8):1010-1014.
2. Van Vlem B., Schoonjans R., Vanholder R., et al. Delayed gastric emptying in dyspeptic chronic hemodialysis patients. Am J Kidney Dis 2000, 36(5):962-968.
3. Karari E.M., Lule G.N., McLigeyo S.O., et al. Endoscopic findings and the prevalence of Helicobacter pylori in chronic renal failure patients with dyspepsia. East Afr Med J 2000, 77(8):406-409.
4. Vaira U., Gatta L., Ricci C., et al. Helicobacter pylori: diseases, tests and treatment. Dig Liver Dis 2001, 33(9):788-794.
5. Francavilla R., Lionetti E., Castellaneta S.P., et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 2005, 129(5):1414-1419.
6. Logan R.P., Gummett P.A., Hegarty B.T., et al. Clarithromycin and omeprazole for Helicobacter pylori. Lancet 1992, 340(8813):239.
7. Khedmat H., Taheri S. Current knowledge on Helicobacter pylori infection in end stage renal disease patients. Saudi J Kidney Dis Transplant 2009, 20(6):969-974.
8. Fabbian F., Catalano C., Bordin V., et al. Esophagogastroduodenoscopy in chronic hemodialysis patients: two-year clinical experience in a renal unit. Clin Nephrol 2002, 58(1):54-59.
9. Abu farsakh N.A., Rowcily E., Rababaa M., et al. Assessment of upper gastrointestinal tract in uremic patients with dialysis. Nephrol Dialysis Transpl 1996, 11:847.
10. Var C., Gultekin F., Candan F., et al. The effects of hemodialysis on duodenal and gastric mucosal changes in uremic patients. Clin Nephrol 1996, 45(5):310-314.
11. Megraud F. Helicobacter pylori resistance to antibiotics: prevalence, mechanism, detection. What's new?. Can J Gastroenterol 2003, 17(Suppl. B):49B-52B.
12. Mégraud F. Basis for the management of drug-resistant Helicobacter pylori infection. Drugs 2004, 64(17):1893-1904.
13. Parsonnet J. Helicobacter pylori. Infect Dis Clin North Am 1998, 12(1):185-197.
14. Fabrizi F., Martin P. Helicobacter pylori infection in patients with end-stage renal disease. Int J Artif Organs 2000, 23(3):157-164.
15. Malfertheiner P., Megraud F., O'Morain C., et al. Current concepts in the management of Helicobacter pylori infection: the maastricht III consensus report. Gut 2007, 56(6):772-781.
16. Bazzoli F., Bianchi Porro G., Bianchi M.G., et al. Treatment of Helicobacter pylori infection. Indications and regimens: an update. Dig Liver Dis 2002, 34(1):70-83.
17. Harris A.W., Misiewicz J.J. Eradication of Helicobacter pylori. Baillieres Clin Gastroenterol 1995, 9(3):583-613.
18. Pamuk O.N., Pamuk G.E., Celik A., et al. Are Turkish Helicobacter pylori strains gaining resistance against clarithromycin?. Am J Gastroenterol 2000, 95(7):1839-1840.
19. Adamek R.J., Suerbaum S., Pfaffenbach B., et al. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole and amoxicillin - influence on treatment outcome. Am J Gastroenterol 1998, 93(3):386-389.
20. Kalach N., Bergeret M., Benhamou P.H., et al. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. J Clin Microbiol 2001, 39(1):394-397.
21. Alarcon T., Domingo D., Lopez Brea M. Antibiotic resistance problems with Helicobacter pylori. Int J Antimicrob Agents 1999, 12(1):19-26.
22. Ellenrieder V., Boeck W., Richter C., et al. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scand J Gastroenterol 1999, 34(8):750-756.
23. Xia H.H.X., Fan X.G., Talley N.J. Clarithromycin resistance in Helicobacter pylori and its clinical relevance. World J Gastroenterol 1999, 5(3):263-266.
24. Aydemir S., Boyacioglu S., Gur G., et al. Helicobacter pylori infection in hemodialysis patients: susceptibility to amoxicillin and clarithromycin. World J Gastroenterol 2005, 11(6):842-845.
25. Luther J., Higgins P.D.R., Schoenfeld P.S., et al. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability. Am J Gastroenterol 2010, 105(1):65-73.
26. Graham D.Y. Efficient identification and evaluation of effective Helicobacter pylori therapies. Clin Gastroenterol Hepatol 2009, 7(2):145-148.